Suppr超能文献

利尿剂与非甾体抗炎药在人体中的相互作用。

Interaction of diuretics and non-steroidal anti-inflammatory drugs in man.

作者信息

Favre L, Glasson P, Riondel A, Vallotton M B

出版信息

Clin Sci (Lond). 1983 Apr;64(4):407-15. doi: 10.1042/cs0640407.

Abstract
  1. The influence of four diuretics on renal prostaglandins was investigated in a study designed in two parts (A and B): A, 24 normal subjects on a constant sodium intake received frusemide (80 mg daily), or hydrochlorothiazide (100 mg), or triamterene (200 mg) or spironolactone (300 mg); B, the same subjects were pretreated for 3 days with indomethacin (150 mg daily), which was continued during the 3 day administration of the respective diuretics and during a 2 day post-diuretic period. 2. In study A, only triamterene provoked a rise in urinary prostaglandins E2 and F2 alpha (+ 474 +/- SEM 92%, P less than 0.01, and + 192 +/- 7%, P less than 0.01). In study B, prostaglandins were significantly inhibited in all subjects. After indomethacin, the natriuretic effect of frusemide and spironolactone was reduced by 80 +/- 12% (P less than 0.01) and 54 +/- 11% (P less than 0.001), whereas the natriuresis induced by hydrochlorothiazide and triamterene was unchanged. No correlation was found between urinary PGE2 and F2 alpha and natriuresis. 3. When triamterene was associated with indomethacin, two subjects developed reversible acute renal failure. 4. Plasma renin activity and urinary aldosterone were stimulated by the four diuretics in study A, but their response was blunted in study B. Urinary antidiuretic hormone was not modified by diuretics but was suppressed by indomethacin. 5. Diflunisal, a structurally unrelated nonsteroidal anti-inflammatory drug, given to 12 of the subjects provoked similar interactions with frusemide, hydrochlorothiazide and spironolactone. 6. The results suggest that prostaglandins contribute to the natriuretic effects of frusemide and spironolactone, but not to those of hydrochlorothiazide and triamterene.
摘要
  1. 在一项分为两部分(A和B)设计的研究中,研究了四种利尿剂对肾前列腺素的影响:A组,24名钠摄入量恒定的正常受试者分别接受速尿(每日80毫克)、氢氯噻嗪(100毫克)、氨苯蝶啶(200毫克)或螺内酯(300毫克);B组,相同的受试者先用消炎痛(每日150毫克)预处理3天,在给予相应利尿剂的3天期间以及利尿剂停用后的2天期间持续使用。2. 在研究A中,只有氨苯蝶啶引起尿前列腺素E2和F2α升高(分别为+474±标准误92%,P<0.01,以及+192±7%,P<0.01)。在研究B中,所有受试者的前列腺素均被显著抑制。消炎痛后,速尿和螺内酯的利钠作用分别降低了80±12%(P<0.01)和54±11%(P<0.001),而氢氯噻嗪和氨苯蝶啶诱导的利钠作用未改变。未发现尿PGE2和F2α与利钠作用之间存在相关性。3. 当氨苯蝶啶与消炎痛合用时,则有两名受试者发生了可逆性急性肾衰竭。4. 在研究A中,四种利尿剂均刺激了血浆肾素活性和尿醛固酮,但在研究B中其反应减弱。利尿剂未改变尿抗利尿激素,但消炎痛使其受到抑制。5. 给12名受试者服用结构不相关的非甾体抗炎药二氟尼柳,可引发与速尿、氢氯噻嗪和螺内酯类似的相互作用。6. 结果表明,前列腺素有助于速尿和螺内酯的利钠作用,但对氢氯噻嗪和氨苯蝶啶的利钠作用无影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验